Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population

Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of general internal medicine : JGIM 2021-07, Vol.36 (7), p.2170-2173
Hauptverfasser: Kozlowski, Steven, Flowers, Natasha, Birger, Noy, Wernecke, Michael, MaCurdy, Thomas E., Kelman, Jeffrey A., Graham, David J.
Format: Artikel
Sprache:eng
Schlagworte:
Concise Research Report
Government programs
Infliximab
Internal Medicine
Medicine
Medicine & Public Health
Monoclonal antibodies
Tumor necrosis factor-α
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2173
container_issue 7
container_start_page 2170
container_title Journal of general internal medicine : JGIM
container_volume 36
creator Kozlowski, Steven
Flowers, Natasha
Birger, Noy
Wernecke, Michael
MaCurdy, Thomas E.
Kelman, Jeffrey A.
Graham, David J.
description
doi_str_mv 10.1007/s11606-020-05957-1
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8298739</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2554122444</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-642edd565b8b13d0e79c467dbd89cabdbebc648c6e31f91a77e63c975d78b1f23</originalsourceid><addsrcrecordid>eNp9kb1uFDEUhS0EIpvAC1BZoqEZ8P9PgwQRkEiJoGBry2Pf2TjM2os9g8LbY9gIBAXVLfx9R_f6IPSMkpeUEP2qUaqIGggjA5FW6oE-QBsqmRyosPoh2hBjxGA0FyfotLVbQihnzDxGJ5xJbQjVG3S9PSz-C2CfI942vwP8yS8L1NxwmfDbVFrap9lXfJmnOd2lvR9xyni5AXwNMQVfu1EO6-yXVPIT9Gjyc4On9_MMbd-_-3x-MVx9_HB5_uZqCELSZVCCQYxSydGMlEcC2gahdByjscGPcYQxKGGCAk4nS73WoHiwWkbdhYnxM_T6mHtYxz3EAHmpfnaH2ver313xyf39ktON25VvzjDb_8P2gBf3AbV8XaEtbp9agHn2GcraHBNUWU44lx19_g96W9aa-3mOSSkoY0KITrEjFWpprcL0exlK3M-23LEt19tyv9pytEv8KLUO5x3UP9H_sX4AOYKW5Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2554122444</pqid></control><display><type>article</type><title>Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>SpringerLink Journals - AutoHoldings</source><creator>Kozlowski, Steven ; Flowers, Natasha ; Birger, Noy ; Wernecke, Michael ; MaCurdy, Thomas E. ; Kelman, Jeffrey A. ; Graham, David J.</creator><creatorcontrib>Kozlowski, Steven ; Flowers, Natasha ; Birger, Noy ; Wernecke, Michael ; MaCurdy, Thomas E. ; Kelman, Jeffrey A. ; Graham, David J.</creatorcontrib><identifier>ISSN: 0884-8734</identifier><identifier>EISSN: 1525-1497</identifier><identifier>DOI: 10.1007/s11606-020-05957-1</identifier><identifier>PMID: 32578017</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Concise Research Report ; Government programs ; Infliximab ; Internal Medicine ; Medicine ; Medicine &amp; Public Health ; Monoclonal antibodies ; Tumor necrosis factor-α</subject><ispartof>Journal of general internal medicine : JGIM, 2021-07, Vol.36 (7), p.2170-2173</ispartof><rights>Society of General Internal Medicine (This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply) 2020</rights><rights>Society of General Internal Medicine (This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply) 2020.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-642edd565b8b13d0e79c467dbd89cabdbebc648c6e31f91a77e63c975d78b1f23</citedby><cites>FETCH-LOGICAL-c451t-642edd565b8b13d0e79c467dbd89cabdbebc648c6e31f91a77e63c975d78b1f23</cites><orcidid>0000-0002-7240-3605</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298739/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298739/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,41464,42533,51294,53766,53768</link.rule.ids></links><search><creatorcontrib>Kozlowski, Steven</creatorcontrib><creatorcontrib>Flowers, Natasha</creatorcontrib><creatorcontrib>Birger, Noy</creatorcontrib><creatorcontrib>Wernecke, Michael</creatorcontrib><creatorcontrib>MaCurdy, Thomas E.</creatorcontrib><creatorcontrib>Kelman, Jeffrey A.</creatorcontrib><creatorcontrib>Graham, David J.</creatorcontrib><title>Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population</title><title>Journal of general internal medicine : JGIM</title><addtitle>J GEN INTERN MED</addtitle><subject>Concise Research Report</subject><subject>Government programs</subject><subject>Infliximab</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Monoclonal antibodies</subject><subject>Tumor necrosis factor-α</subject><issn>0884-8734</issn><issn>1525-1497</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kb1uFDEUhS0EIpvAC1BZoqEZ8P9PgwQRkEiJoGBry2Pf2TjM2os9g8LbY9gIBAXVLfx9R_f6IPSMkpeUEP2qUaqIGggjA5FW6oE-QBsqmRyosPoh2hBjxGA0FyfotLVbQihnzDxGJ5xJbQjVG3S9PSz-C2CfI942vwP8yS8L1NxwmfDbVFrap9lXfJmnOd2lvR9xyni5AXwNMQVfu1EO6-yXVPIT9Gjyc4On9_MMbd-_-3x-MVx9_HB5_uZqCELSZVCCQYxSydGMlEcC2gahdByjscGPcYQxKGGCAk4nS73WoHiwWkbdhYnxM_T6mHtYxz3EAHmpfnaH2ver313xyf39ktON25VvzjDb_8P2gBf3AbV8XaEtbp9agHn2GcraHBNUWU44lx19_g96W9aa-3mOSSkoY0KITrEjFWpprcL0exlK3M-23LEt19tyv9pytEv8KLUO5x3UP9H_sX4AOYKW5Q</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Kozlowski, Steven</creator><creator>Flowers, Natasha</creator><creator>Birger, Noy</creator><creator>Wernecke, Michael</creator><creator>MaCurdy, Thomas E.</creator><creator>Kelman, Jeffrey A.</creator><creator>Graham, David J.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7240-3605</orcidid></search><sort><creationdate>20210701</creationdate><title>Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population</title><author>Kozlowski, Steven ; Flowers, Natasha ; Birger, Noy ; Wernecke, Michael ; MaCurdy, Thomas E. ; Kelman, Jeffrey A. ; Graham, David J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-642edd565b8b13d0e79c467dbd89cabdbebc648c6e31f91a77e63c975d78b1f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Concise Research Report</topic><topic>Government programs</topic><topic>Infliximab</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Monoclonal antibodies</topic><topic>Tumor necrosis factor-α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kozlowski, Steven</creatorcontrib><creatorcontrib>Flowers, Natasha</creatorcontrib><creatorcontrib>Birger, Noy</creatorcontrib><creatorcontrib>Wernecke, Michael</creatorcontrib><creatorcontrib>MaCurdy, Thomas E.</creatorcontrib><creatorcontrib>Kelman, Jeffrey A.</creatorcontrib><creatorcontrib>Graham, David J.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of general internal medicine : JGIM</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kozlowski, Steven</au><au>Flowers, Natasha</au><au>Birger, Noy</au><au>Wernecke, Michael</au><au>MaCurdy, Thomas E.</au><au>Kelman, Jeffrey A.</au><au>Graham, David J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population</atitle><jtitle>Journal of general internal medicine : JGIM</jtitle><stitle>J GEN INTERN MED</stitle><date>2021-07-01</date><risdate>2021</risdate><volume>36</volume><issue>7</issue><spage>2170</spage><epage>2173</epage><pages>2170-2173</pages><issn>0884-8734</issn><eissn>1525-1497</eissn><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>32578017</pmid><doi>10.1007/s11606-020-05957-1</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-7240-3605</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0884-8734
ispartof Journal of general internal medicine : JGIM, 2021-07, Vol.36 (7), p.2170-2173
issn 0884-8734
1525-1497
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8298739
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; SpringerLink Journals - AutoHoldings
subjects Concise Research Report
Government programs
Infliximab
Internal Medicine
Medicine
Medicine & Public Health
Monoclonal antibodies
Tumor necrosis factor-α
title Uptake and Usage Patterns of Biosimilar Infliximab in the Medicare Population
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A17%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Uptake%20and%20Usage%20Patterns%20of%20Biosimilar%20Infliximab%20in%20the%20Medicare%20Population&rft.jtitle=Journal%20of%20general%20internal%20medicine%20:%20JGIM&rft.au=Kozlowski,%20Steven&rft.date=2021-07-01&rft.volume=36&rft.issue=7&rft.spage=2170&rft.epage=2173&rft.pages=2170-2173&rft.issn=0884-8734&rft.eissn=1525-1497&rft_id=info:doi/10.1007/s11606-020-05957-1&rft_dat=%3Cproquest_pubme%3E2554122444%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2554122444&rft_id=info:pmid/32578017&rfr_iscdi=true